| Product Name | MF | CAS | Details |
|---|
| Azido-PEG1-NHS ester | C9H12N4O5 | 1807530-06-8 | Details |
| 4-Bromo-5-cyclopropyl-1,3-thiazole | C6H6BrNS | 1264037-53-7 | Details |
| 5-Chloro-2-hydroxybenzene-1-carboximidamide hydrochloride | C7H8Cl2N2O | 1795436-91-7 | Details |
| 2-Ethynyl-5-methylpyridine | C8H7N | 30413-61-7 | Details |
| 7-Methoxy-2,3,4,5-tetrahydro-1-benzoxepin-5-one | C11H12O3 | 55580-00-2 | Details |
| 4-(Bromomethyl)phenylacetic acid | C9H9BrO2 | 13737-36-5 | Details |
| 2-(3,5-Dichlorophenyl)-4,4-dimethyl-5-methylidene-4,5-dihydro-1,3-oxazole | C12H11Cl2NO | 29918-40-9 | Details |
| N4-Methyl-2'-O-methyl-cytidine | C11H17N3O5 | 13048-95-8 | Details |
| 3-(4-Fluorophenyl)-1-[2-(piperazin-1-yl)ethyl]urea dihydrochloride | 2378503-44-5 | Details |
| Anti-S1PR1 antibody R1G - 0.5mg/mL | Details |
| 2-((prop-2-enylamino)ethylidene)indane-1,3-dione | C14H13NO2 | 362498-91-7 | Details |
| N-Methylazetidine-3-carboxamide hydrochloride | C5H11ClN2O | 864248-69-1 | Details |
| Azacycloundecan-2-one | C10H19NO | 1009-89-8 | Details |
| Recombinant Human FGF-Basic | C62H95N15O15 | 62031-54-3 | Details |
| 5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine dihydrochloride | C6H10ClN3 | 735266-95-2 | Details |
| (S)-(+)-4-Phenyl-2-oxazolidinone | C9H9NO2 | 99395-88-7 | Details |
| 1-(3-Fluorophenyl)-3-methyl-1H-pyrazole-4-carbaldehyde | C11H9FN2O | 1143517-63-8 | Details |
| 1-(Oxan-2-yl)propan-1-amine | C8H17NO | 1602058-43-4 | Details |
| 3-Methyl-2-[2-(naphthalen-2-yl)acetamido]butanoic acid | C17H19NO3 | 1396968-66-3 | Details |
| Rhodomyrtosone A | C26H32O7 | 1079988-16-1 | Details |
| Chlorphenamine EP Impurity D maleate salt | C17H18ClN3 | 65676-21-3 | Details |
| 3-(3-Bromo-4-hydroxy-5-methoxyphenyl)prop-2-enoic acid | C10H9BrO4 | 948051-10-3 | Details |
| C2ORF18 Blocking Peptide | Details |
| Azetidin-3-yl N-(propan-2-yl)carbamate hydrochloride | C7H15ClN2O2 | 1803601-99-1 | Details |
| N-(4-Bromophenyl)-N-phenylacrylamide | C15H12BrNO | 1956368-15-2 | Details |
| 1-Methylcyclopropane-1-carboxylic acid | C5H8O2 | 6914-76-7 | Details |
| 4-(4-Formylphenoxy)-piperidine-1-carboxylic acid tert-butyl ester | C17H23NO4 | 207798-38-7 | Details |
| (3R,5r)-5-Methylpyrrolidin-3-ol HCl | C5H12ClNO | 857651-11-7 | Details |
| Diacetoxy-4-gingerdiol | C19H28O6 | 863780-88-5 | Details |
| Bromo-2-tetraacetyl galactose | C14H19BrO10 | Details |
| Spiro[1,3-dioxaindane-2,4'-piperidine] | C11H13NO2 | 7677-96-5 | Details |
| 1-Methylene-5-a-androstan-3-a-ol-17-one glucuronide | C26H37O8.Na.2H2O | Details |
| 1-Benzylpiperazin-2-one | C11H14N2O | 59702-21-5 | Details |
| 2,10-diaza-9-(4-hydroxy-3,5-dimethoxyphenyl)-5,5,13-trimethyltricyclo[9.4.0.0<,3,8>,]pentadeca-1(15),3(8),11(12),13-tetraen-7-one | C24H28N2O4 | 1020252-03-2 | Details |
| 4-(Chloromercuri)benzenesulfonic acid sodium salt | C6H4ClHgNaO3S | 14110-97-5 | Details |
| 2,5-Dimethyl-1-(2-methylpropyl)-1H-pyrrole-3-carbaldehyde | C11H17NO | 730950-24-0 | Details |
| Casein kinase 2 antibody (HRP) | Details |
| 1-Benzyl-4-methylpyrrolidin-3-one | C12H15NO | 69079-25-0 | Details |
| 1-(Dimethylamino)-2-methylpropan-2-ol | C6H15NO | 14123-48-9 | Details |
| 5-Hydroxy-6-methylpyridine-2-carbonitrile | C7H6N2O | 1211589-52-4 | Details |
| 1-(tert-Butoxy)-3-chlorocyclobutane | C8H15ClO | 1909287-23-5 | Details |
| 1,2-O-Isopropylidene-sn-glycerol | C6H12O3 | 22323-82-6 | Details |
| N,N'-Dimethyl benzamide | C9H11NO | 611-74-5 | Details |
| H-ASNTAEVFFDGVR-OH | Details |
| Dactylorhin E | C27H40O16 | 256459-40-2 | Details |
| Eflornithine | C6H12F2N2O2 | 70052-12-9 | Details |
| 4H,6H,7H-Pyrano[3,4-d][1,2]oxazole-3-carbaldehyde | C7H7NO3 | 1556047-58-5 | Details |
| 3-(N-Methyl-N-pentylamino)propionic acid hydrochloride | C9H20ClNO2 | 625120-81-2 | Details |
| (R)-4-Chloro-3-hydroxybutyronitrile | C4H6ClNO | 84367-31-7 | Details |
| D-Fructose-6-phosphate sodium hydrate | C6H16NaO10P | 918149-30-1 | Details |
| 1-[2,3-O-Isopropylidene-b-D-ribofuranosyl]-1,2,4-triazole-3-carboxylic acid methyl ester | C12H17N3O6 | 594860-43-2 | Details |
| Melanin - fungal (Ganoderma lucidum) | C18H10N2O4 | 8049-97-6 | Details |
| Methyl 4-cyanopiperidine-4-carboxylate hydrochloride | C8H13ClN2O2 | 1205749-65-0 | Details |
| LHX2 antibody | Details |
| 1-{2-Fluoro-4-[(2,4,6-trimethylphenyl)methoxy]phenyl}ethan-1-one | C18H19FO2 | 1389653-59-1 | Details |
| ACTL7B Blocking Peptide | Details |
| 2-(3-Bromo-5-chlorophenyl)ethan-1-amine hydrochloride | 2094935-75-6 | Details |
| OR8D1 antibody | Details |
| 1-Ethyl-2-(4-methylphenoxymethyl)-1H-1,3-benzodiazole | C17H18N2O | 433328-82-6 | Details |
| [3,3-Dimethyl-1-(pyridin-2-yl)butan-2-yl](methyl)amine | C12H20N2 | 1248995-71-2 | Details |
| 3,5-Dichloro-L-tyrosine | C9H9Cl2NO3 | 15106-62-4 | Details |
| Methyl N-benzyl-4,6-dideoxy-4,6-imino-2,3-O-isopropylidene-b-D-talopyranoside | Details |
| N,N-Diethyl-3,5-dimethyl-1H-pyrazole-4-sulfonamide | C9H17N3O2S | 944416-16-4 | Details |
| C2orf28 Blocking Peptide | Details |
| 1-Deoxy- 4- C- methyl- 3, 4-isopropylidene-L- erythro- 2- pentulose | Details |
| 1,3,3-Trimethyl-2-oxabicyclo[2.1.1]hexane-4-carboxylic acid | C9H14O3 | 2219371-57-8 | Details |
| CHPF antibody | Details |
| (D-Pro7)-Angiotensin I/II (1-7) | C41H62N12O11 | 586962-44-9 | Details |
| 3,4-Dihydro-2H-benzo[E][1,2,4]thiadiazine 1,1-dioxide | C7H8N2O2S | 359-84-2 | Details |
| H-FLYGALLLA-OH | Details |
| Erk Inhibitor | C14H16N2O3S | 294675-79-9 | Details |
| 3-Methyl-5-(trifluoromethyl)isoxazole-4-carboxylic acid | C6H4F3NO3 | 193952-09-9 | Details |
| Pseudorabies Virus antibody | Details |
| TLR9 antibody | Details |
| (2Z)-2-(Acetylamino)-3-(4-chlorophenyl)acrylic acid | C11H10ClNO3 | 3617-00-3 | Details |
| rac-(1R,2R)-1-Amino-2-methylcyclopropane-1-carboxylic acid hydrochloride | C5H9NO2.ClH | 100819-58-7 | Details |
| H-Gly-Pro-pNA?hydrochloride | C13H17ClN4O4 | 103213-34-9 | Details |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)butanamide | C12H15NO3 | 423151-36-4 | Details |
| 2-Chloro-1-(1-methanesulfonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)ethan-1-one | C12H14ClNO3S | 852388-73-9 | Details |
| 4-Methoxy-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine | C7H9N5O | 1782450-68-3 | Details |
| (1-Methyl-3-phenyl-1H-pyrazol-4-yl)methanol | C11H12N2O | 499770-87-5 | Details |
| RBM42 antibody | Details |
| 4-(1H-Imidazol-2-yl)butan-1-amine dihydrochloride | C7H14ClN3 | 33544-92-2 | Details |
| 1-(1-Methyl-1H-1,2,3-triazol-4-yl)ethan-1-ol | C5H9N3O | 1022093-96-4 | Details |
| 1,4-Diazabicyclo[2.2.2]octan-2-ylmethanamine | C7H15N3 | 186348-51-6 | Details |
| 1-[(4-Fluorophenyl)methyl]pyrrolidine-3-carboxylic acid hydrochloride | C12H15ClFNO2 | 1831751-97-3 | Details |
| CEL antibody | Details |
| Ethyl 4-{[(tert-butoxy)carbonyl]amino}piperidine-3-carboxylate hydrochloride | 2193061-65-1 | Details |
| Tyrosine Protein Kinase JAK 2 | C88H138N20O34P2 | Details |
| Prepro-Neuromedin S (70-103) (human) trifluoroacetate salt | Details |
| methyl 3-indol-3-yl-2-(3-(4-(isopropyl)phenyl)prop-2-enoylamino)propanoate | C24H26N2O3 | Details |
| MIP3 beta protein | Details |
| Hexasodium phytate | C6H19NaO24P6 | 34367-89-0 | Details |
| 2-{[2-(Methoxymethyl)phenyl]amino}benzonitrile | C15H14N2O | 1275714-59-4 | Details |
| TNF a Mouse | Details |
| NSMCE1 antibody | Details |
| 1-(Aminomethyl)cyclopropanamine dihydrochloride | C4H12Cl2N2 | 849149-67-3 | Details |
| 4-Methoxy-N,N-dimethylpyrimidin-2-amine | C7H11N3O | 1197-11-1 | Details |
| THETA gamma Globulin antibody | Details |
| MPO Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 | ||||